| Zacks Company Profile for Lotus Pharmaceuticals Inc. (LTUS : OTC) |
|
|
| |
| • Company Description |
| Lotus Pharmaceuticals, Inc. operates, controls and owns the pharmaceutical businesses in China of Beijing Liang Fang Pharmaceutical Co., Ltd. and Beijing En Zhe Jia Shi Pharmaceutical Co., Ltd., collectively Lotus East. The Company believes Lotus East has some of the most advanced pharmaceutical production equipment in China and its manufacturing facilities meet national Good Manufacturing Practices. The Company distributes its own portfolio of drugs and pharmaceutical products produced by other manufacturers in the People's Republic of China through an extensive national distribution network. Liang Fang owns and operates drug stores throughout Beijing, China that sell Western and traditional Chinese medications and lease medical treatment facilities to licensed physicians. En Zhe Jia is a manufacturer for Liang Fang and maintains facilities for the production of medicines, Chinese medicine, as well as the research and production of other new medicines.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.01 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 23,487 shares |
| Shares Outstanding: 2,644.52 (millions) |
| Market Capitalization: $29.09 (millions) |
| Beta: -2.48 |
| 52 Week High: $0.01 |
| 52 Week Low: $0.00 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
39.24% |
34.03% |
| 12 Week |
74.60% |
46.86% |
| Year To Date |
83.33% |
71.69% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
16 CHENG ZHUANG ROAD FENG TAI DISTRICT
-
BEIJING,F4 100071
CHN |
ph: 86-10-6389-9868
fax: 86-10-6389-9867 |
None |
http://www.lotuspharma.com |
|
|
| |
| • General Corporate Information |
Officers
Dr.Liu Zhongyi - C.E.O & Director
Ms.Zeng Yan - Chief Financial Officer
Dr.Ian Ashley - Director
Ms.Li Ping - Director
Mr.Liu Jin - Director
|
|
Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 545715203
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/24
Next Expected EPS Date: 08/15/25
|
|
Share - Related Items
Shares Outstanding: 2,644.52
Most Recent Split Date: 12.00 (0.50:1)
Beta: -2.48
Market Capitalization: $29.09 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/15/25 |
|
|
|
| |
